Bon's human microbiome treatment hits China
10 Feb 2022 --- Last month, Bon Natural Life (Bon) received an initial purchase order from Chongqing Fudoudou Technology (FDD) for FeatherPure Women's Personal Care Gel; a product which provides female reproductive system care. The orders are now being shipped to the wholly-owned subsidiary Chongqing Jingfubao Trading.
FeatherPure is one of the first female personal care products that leverages human microbiome technologies using Bon’s proprietary stachyose and apple extract formulation, the company states. The product is also all-natural with no antibiotics, fragrance, harmful chemical additives or harmful side effects. In a recent press release, Bon stated: “Aiming to achieve a healthy microbial balance of the female reproductive system, FeatherPure also helps adjust the pH value of the female reproductive system to a desirable level and has anti-bacterial and anti-inflammatory functions.” The company expects FeatherPure will achieve approximately US$3m in revenue in the next two years.
Click to EnlargeYongwei Hu is looking forward to greater involvement in the Chinese market. Source: Bon Natural Life“The company believes that there is currently a big gap in human microbiome treatments for regular skin care, facial acnes/infection and pattern hair loss,” says Yongwei Hu, Chairman and CEO of Bon. Skin care, facial acne and hair loss are highly related to the human microbiome balance, Bon notes, which is what the brand specializes in. “With Bon’s expertise in human microbiome technology, the company has formed its unique theories and developed its proprietary and efficient microbiome solutions for such health issues.”
Meanwhile, Bon has also forged strong supply chain links which enable it to fill a gap in the personal care market. "We are excited to officially kick off the partnership with FDD. This represents a unique opportunity for Bon to gain enhanced access to FDD's extensive retail consumer network," comments Hu. "As adoption of women's health awareness continues to rise, we expect women's health expenditure will grow exponentially and FeatherPure will take the lead in the market.”
Bon has developed its proprietary stachyose and apple extract-based personal care products to tackle common issues, Hu shares: “As a common disease in the female reproductive system, inflammation could usually be treated with regular female personal care gel or antibiotics to achieve a decent initial effect. However, due to the longstanding dysbacteria in the genital tract, which is common in inflammation cases, the recurrence rate is excessively high, up to 80%, which makes it a predicament of such diseases and health issues.”
Applying Bon’s research and development in human microbiome health, Hu states: “The proprietary formula Stachyose + Apple Extract can proliferate probiotics and inhibit the growth of harmful bacteria to reduce the inflammatory syndromes in the female reproductive system.” In addition, Bon also notes how its extract helps to improve microbial balance and hence decrease the recurrence rate of such disease.
Short-term gain, long-term goals
FDD operates a leading e-commerce and new retail platform specializing in marketing and selling health and personal care products in China. Bon sought to combine its strong supply chain capability with FDD’s extensive sales channels and consumer network.
“Meanwhile, there is a huge market demand and opportunity for female personal care products, which provides a solid foundation for this working relationship,” says Hu. “The company believes that the partnership with FDD to introduce high-quality proprietary health products to consumers in China is a natural utilization and extension of the company’s core competence in the bio-ingredient business.”
In the future, Bon hopes to work with FDD in two ways. First, on the product side, the bio-ingredient manufacturer plans to develop and manufacture white label products based on market feedback and demand from FDD. Then, in terms of strategy, Bon and FDD will target other partnership and development opportunities in the health and personal care industry on a higher strategic level, bringing together Bon’s technologies and supply chain advantages with FDD’s extensive consumer and sales network.
Click to EnlargeFeatherPure aims to prevent recurring issues for women. Source: Bon Natural LifeFDD demonstrated a specific interest in FeatherPure Women's Personal Care Gel. Bon details that the product’s functions include: reducing inflammatory syndromes in the female reproductive system; anti-aging of the female reproductive system; daily cleaning and hygiene; care before and after sexual activities; and cleaning and hygienic care during the menstrual period. Citing the product’s advantages, Hu says: “FDD is interested in this product mainly due to its unique microbiome technology, remarkable effect and all-natural ingredients.”
Bon confirms its plans to continue its relationship with FDD for the roll-out of other products. The manufacturer is currently in preliminary communications with FDD about co-developing two products: a weight management offering and an anti-aging item. “At the same time, we are currently in communication with FDD about co-developing other healthcare products in response to the vast market demand,” shares Hu.
In 2022, Bon intends to focus on “brand sorting and positioning”, Hu shares. Bon will target the global market by analyzing its own strategic goals and market trends to reposition its functional dietary supplement brand, Dietary Therapy Health, and personal care brand, Semico.
The company also told BPC Insights that it plans to launch two to three new products in 2022 in different phases. By analyzing healthcare and personal care market trends and combining its expertise in human microbiome technologies, Bon has ambitions to develop probiotic products that seek to support consumers’ digestive health, metabolism, brain health and anti-aging goals.
Bon also plans to expand its research and development centers in both China and the US, directing its efforts towards its target market in the former. At the same time, the company wants to expand its business operational footprint on a global level, including in the US, Europe and Japan. “We believe that the partnership with FDD will be an additional source of revenue growth with an expected revenue increase of US$10m in three years, and will create more compelling values to our shareholders,” Hu reveals.
By Natasha Spencer-Jolliffe, BPC Insights Senior Journalist
